The Pharmacovigilance Europe Congress held the 11th Pharmacovigilance Europe Conference in London on 15th and 16th May 2024.
This was exciting news as our Chief Medical Officer, Dr. Stephanie Jones, took part in the conference!
Dr. Jones was a panel member for several discussions, including: “The Benefits and Challenges of PV Outsourcing”, where she emphasised the value of patient safety throughout the product life cycle, drawing on Pharmora’s recent experiences, including how safety helped to save a clinical trial; and “Global Harmonization of Pharmacovigilance Regulations: Progress and Roadblocks”. Dr Jones had just returned from a conference on the regulation of AI in Pharmacovigilance and was able to provide relevant insights from those discussions.
This year’s theme was “Synergies in Safeguarding Health: Unveiling the Future of Pharmacovigilance”. The theme of synergy and cooperation seems fitting in a time when global 
communication is so accessible, and patient safety extends across borders with reports coming in from multiple sources within any country.
The conference had attendees including pharmaceutical and biotechnology industry pioneers, who were able to inform the audience about the latest information and developments. Additionally, members of clinical research organisations attended, and spoke on topics such as pharmacovigilance, regulatory affairs, risk management and clinical trials.
As well as this, there was ample opportunity to network and interact with industry experts, like Dr. Jones and Pharmora Principal Scientist, John O’Brien. A truly memorable event!
To find out more about this annual conference, please follow this link.
Or Click here to go to Pharmora’s Home Page
